Emil J Freireich, M.D., Oral History Interview Session 01, October 5, 2011, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Sessions

Chapter 05: New Chemotherapy Treatments for Breast and Cultural Challenges to Research Innovation, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 04: MD Anderson Changes Under Charles LeMaistre: Expansions in Leukemia Research, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 03: Perfecting the Blood Separator in the Department of Developmental Therapeutics: Shifting MD Anderson Culture to Innovative Research, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 02: Building the Continuous-Flow Blood Separator, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 01: A New Idea and A Controversy: Transfusing Platelets in Leukemia Patients, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 07: Building the "Best Graduate Medical Education Program in the Country", Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 06: A Commitment to Training and Education: A Failed Battle For an MD Anderson Medical School, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 09: Creating Patient-Oriented Research in a Complex Scientific and Institutional Context, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 08: A History of Institutional Grand Rounds, The Core Curriculum, and the Physician's Assistant Training Program, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 10: Advocating for Patient-Oriented Research and Patients, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Emil J Freireich, M.D., Oral History Interview Session 02, October 6, 2011, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Sessions

Emil J Freireich, M.D., Oral History Interview Session 03, October 11, 2011, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Sessions

Chapter 16: A Life of Work with the Support of a Strong Wife and Family, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 15: A Legacy of Strong Faculty and Advances in Blood Cancers; Awards; as a Disease and MD Anderson Presidents, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 14: The Partnership Between Basic Science and Clinical Research, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 13: Leukemia as a Key to Understanding, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 12: The FDA as a Barrier to Research Innovation, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

Chapter 11: A Critical Need to Fund Patient-Oriented Research, Emil J. Freireich MD, Tacey A. Rosolowski PhD
Interview Chapters

The History of the University of Texas MD Anderson Cancer Center, Emil J. Freireich MD
University of Texas MD Anderson Cancer Center Historical Video Collection

OncoLog, Volume 49, Number 05, May 2004, David Galloway, Dawn Chalaire, Emil J. Freireich MD
OncoLog MD Anderson's Report to Physicians (All issues)

Emil Freireich, MD, Oral History Interview, August 06, 2001, Emil J. Freireich MD, Lesley W. Brunet
Interview Sessions

Chapter 20: A “Flexner Report for Cancer” and Commitment to Education, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 22: An NCI Audit and Problems with a Protocol and Leadership, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 21: Views of Charles A. LeMaistre and MD and R. Lee Clark, MD, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 19: Head of the Adult Leukemia Program and a “Project Reassignment” Year at the NIH, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 18: Departments Undergoing Change under Charles LeMaistre, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 17: The Beginning of the Division System, Closing Developmental Therapeutics (1983), and the Legacy of the Department, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 16: Charles LeMaistre, the New President, Initiates Reorganization, with Impact on Developmental Therapeutics, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 28: The Physician-Scientist Training Program and Other Activities and Some Thoughts on Retirement, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 27: The Development of the ALZA Infusion Pump, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 26: Reflections on Leadership Style, Intellectual Freedom, and MD Anderson, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 25: Multi-Disciplinary Clinics in a Politicized Environment and a Review of Key MD Anderson People [Restricted], Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 24: Controversies over Use of Drugs in Clinical Trials (1980s), Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 23: Charles A. LeMaistre’s Administrative Success, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Emil Freireich, MD, Oral History Interview, August 13, 2001, Emil J. Freireich MD, Lesley W. Brunet
Interview Sessions

Emil J Freireich, MD, Oral History Interview, July 23, 2001, Emil J. Freireich MD, Lesley W. Brunet
Interview Sessions

Chapter 04: Oncology Research at a New Hospital at the National Institutes of Health, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 08: A Research Controversy: Treating Hemorrhage in Childhood Leukemia, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 07: Treating Hemorrhage in Pediatric Leukemia Patients, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 06: The First Systematic Studies of Chemotherapy for Leukemia, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 05: Treating Leukemia at the NIH, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 03: On to a Fellowship in Boston and to Hematology, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 02: Medical School and Residency in Chicago and a Growing Interest in the Science of Medicine, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 01: Growing Up in Chicago with Unusual Opportunities, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Emil Freireich, MD, Oral History Interview, July 30, 2001, Emil J. Freireich MD, Lesley W. Brunet
Interview Sessions

Chapter 15: Developmental Therapeutics, the Division of Medicine, and Dr. Clark’s Final Years as President, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 14: Developmental Therapeutics in the Midst of Opposition to Systemic Treatment of Cancer, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 13: Getting to Work, Diving into Controversy, and Studies of POMP, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 12: The Lay of the Land: Developmental Therapeutics and MD Anderson in 1965, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 11: Leaving the NIH for a Turbulent Research Environment at MD Anderson, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 10: At the NIH: Vincristine, a Cure for Childhood Leukemia, and VAMP, Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

Chapter 09: At the NIH: Studying Infection in Leukemic Patients [early 60s], Emil J. Freireich MD, Lesley W. Brunet
Interview Chapters

OncoLog, Volume 46, Number 01, January 2001, Kerry L. Wright, Dawn Chalaire, Emil J. Freireich MD
OncoLog MD Anderson's Report to Physicians (All issues)

OncoLog, Volume 36, Issue 03, July-September 1991, Emil J. Freireich MD, James M. Bowen
OncoLog MD Anderson's Report to Physicians (All issues)